MoneyWorks4Me

Laurus Labs informs about outcome of board meeting

29 Oct 2020 Evaluate
Laurus Labs has informed that the Board of Directors have approved the unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half year ended September 30, 2020 at their meeting held on October 29, 2020, which are enclosed herewith along with the Limited Review Reports issued by Deloitte Haskins & Sells LLP, the Statutory Auditors of the Company. The financial results are also available on the website of the Company at www.lauruslabs.com and also on the websites of BSE and National Stock Exchange of India, viz. www.bseindia.com and www.nseinda.com respectively. The Board Meeting commenced at 2.00 PM and concluded at 3.00 PM.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..